Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Do Xanthine Oxidase Inhibitors Regress Left Ventricular Hypertrophy in Diabetes?
2008-008485-12Phase 4Terminated
- Sponsor
- University of Dundee
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of allopurinol in type 2 diabetes mellitus (T2DM) and left ventricular hypertrophy (LVH), sponsored by University of Dundee. Primary endpoint: Left ventricular hypertrophy regression on cardiac MRI. Started May 2009; status: terminated.
02
Drugs
allopurinol
03
Conditions
type 2 diabetes mellitus (T2DM)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on 2008-008485-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008485-12.